17 Questions
Which factor is NOT associated with unreliable GI absorption when considering IV-to-PO conversion?
Endothelial injury
What is recommended as a minimum daily glucose intake during parenteral therapy?
50-100 g
In the context of VTE prophylaxis, which patient population typically has a higher risk of developing VTE?
ICU patients
According to Virchow’s triad, which factor contributes to the risk of venous thromboembolism?
Endothelial injury
What is the purpose of individualized risk:benefit analysis in the context of anticoagulation therapy?
To assess the risk and benefits tailored to each patient
Which of the following patients would typically be ruled out based on contraindications for anticoagulation therapy?
A patient who had spinal cord surgery 25 days ago
Why is routine monitoring only needed with unfractionated heparin (UFH) and not with low molecular weight heparin (LMWH)?
Because UFH has unpredictable pharmacokinetics and needs monitoring
What should be considered when deciding to convert from IV to PO therapy?
Cost-effectiveness and side effects
In the context of unreliable GI absorption, which condition is NOT listed as a concern?
Uncontrolled constipation
What is a common harm associated with VTE prophylaxis mentioned in the text?
Venous thromboembolism
Which factor does NOT contribute to Virchow’s triad for venous thromboembolism risk?
Hyperglycemia
When considering anticoagulation therapy contraindications, which patient population is typically excluded?
Patients with a history of hypertension
What is a characteristic of a population-based approach to anticoagulation therapy?
It generally assumes benefit outweighs harm
Which factor would lead to ruling out a patient for anticoagulation therapy based on contraindications?
Active bleeding
Why is routine monitoring only needed with unfractionated heparin (UFH) and not with low molecular weight heparin (LMWH)?
LMWH has more predictable pharmacokinetics than UFH
What defines chronic kidney disease (CKD) in terms of duration according to the text?
3 or more months
Which parameter necessitates routine monitoring only with unfractionated heparin (UFH) and not with LMWH?
Every 2-3 days monitoring from day 4-14
Test your understanding of the review of previous institutional knowledge related to parenteral therapy and IV-to-PO conversion recommendations. Explore concepts such as glucose requirements, antibiotic conversion, and safety monitoring.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
